'Disease Experts Predict A Small Rise In Covid-19 Cases This Summer' - CNBC
Portfolio Pulse from Benzinga Newsdesk
Disease experts predict a small rise in Covid-19 cases this summer, but it is not expected to be as serious as previous years. Dr. Kavita Patel provides insights on the expected increase and the transmissibility of the new variant.
May 22, 2024 | 2:59 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
AstraZeneca may see a slight increase in demand for its Covid-19 vaccine due to the predicted rise in cases.
The predicted rise in Covid-19 cases could lead to increased demand for vaccines, benefiting AstraZeneca.
CONFIDENCE 80
IMPORTANCE 60
RELEVANCE 50
POSITIVE IMPACT
BioNTech may experience a moderate increase in vaccine sales due to the anticipated rise in Covid-19 cases.
The expected increase in Covid-19 cases could drive higher demand for BioNTech's vaccines.
CONFIDENCE 80
IMPORTANCE 60
RELEVANCE 50
POSITIVE IMPACT
Johnson & Johnson could see a slight rise in vaccine demand due to the predicted increase in Covid-19 cases.
The anticipated rise in Covid-19 cases could lead to increased demand for Johnson & Johnson's vaccines.
CONFIDENCE 80
IMPORTANCE 60
RELEVANCE 50
POSITIVE IMPACT
Moderna is likely to see a moderate increase in vaccine sales due to the expected rise in Covid-19 cases.
The predicted rise in Covid-19 cases could drive higher demand for Moderna's vaccines.
CONFIDENCE 80
IMPORTANCE 60
RELEVANCE 50
POSITIVE IMPACT
Novavax may experience a slight increase in vaccine demand due to the anticipated rise in Covid-19 cases.
The expected increase in Covid-19 cases could lead to higher demand for Novavax's vaccines.
CONFIDENCE 80
IMPORTANCE 60
RELEVANCE 50
POSITIVE IMPACT
Pfizer is likely to see a moderate increase in vaccine sales due to the predicted rise in Covid-19 cases.
The predicted rise in Covid-19 cases could drive higher demand for Pfizer's vaccines.
CONFIDENCE 80
IMPORTANCE 60
RELEVANCE 50